StockData
Castle Biosciences Inc logo

Castle Biosciences Inc (CSTL) stock

CSTLNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/304% below fair value
$32.98+0.23 (+0.70%)

Close on Nov 17, 2026Market cap $1.01BP/E –Yield 0.00%

Castle Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Castle Biosciences's price to book ratio was 2.2× on Nov 11, 2026, against 2.5× a year earlier. Over the last 5 years it ranged from 1.0× to 2.8×, with a median of 1.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.2×−0.2
2025Dec 31, 20252.4×+0.7
2024Dec 31, 20241.7×+0.2
2023Dec 29, 20231.5×−0.0
2022Dec 30, 20221.5×−1.1
2021Dec 31, 20212.6×−5.4
2020Dec 31, 20208.0×+0.9
2019Dec 31, 20197.1×–

More Castle Biosciences figures

See a number that looks wrong?